Singapore markets open in 3 hours 14 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,064.20 +45.81 (+0.91%) Dow
38,225.66 +322.37 (+0.85%) Nasdaq
15,840.96 +235.48 (+1.51%) Bitcoin USD
59,302.48 +1,577.20 (+2.73%) CMC Crypto 200
1,270.55 -0.19 (-0.02%)
Treace Medical Concepts, Inc. (TMCI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 672.62M |
| Enterprise value | 619.73M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.53 |
| Price/book (mrq) | 4.88 |
| Enterprise value/revenue | 3.31 |
| Enterprise value/EBITDA | -15.89 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.28 |
| 52-week change 3 | -58.79% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 27.70 |
| 52-week low 3 | 5.27 |
| 50-day moving average 3 | 12.31 |
| 200-day moving average 3 | 13.14 |
Share statistics
| Avg vol (3-month) 3 | 399.62k |
| Avg vol (10-day) 3 | 348.61k |
| Shares outstanding 5 | 61.94M |
| Implied shares outstanding 6 | 61.94M |
| Float 8 | 44.28M |
| % held by insiders 1 | 25.91% |
| % held by institutions 1 | 67.47% |
| Shares short (15 Apr 2024) 4 | 2.76M |
| Short ratio (15 Apr 2024) 4 | 7.64 |
| Short % of float (15 Apr 2024) 4 | 5.71% |
| Short % of shares outstanding (15 Apr 2024) 4 | 4.45% |
| Shares short (prior month 15 Mar 2024) 4 | 2.93M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -26.47% |
| Operating margin (ttm) | -10.78% |
Management effectiveness
| Return on assets (ttm) | -15.59% |
| Return on equity (ttm) | -49.91% |
Income statement
| Revenue (ttm) | 187.12M |
| Revenue per share (ttm) | 3.08 |
| Quarterly revenue growth (yoy) | 25.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -46.39M |
| Net income avi to common (ttm) | -49.53M |
| Diluted EPS (ttm) | -0.81 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 123.2M |
| Total cash per share (mrq) | 2 |
| Total debt (mrq) | 70.3M |
| Total debt/equity (mrq) | 50.97% |
| Current ratio (mrq) | 4.41 |
| Book value per share (mrq) | 2.23 |
Cash flow statement
| Operating cash flow (ttm) | -34.58M |
| Levered free cash flow (ttm) | -33.02M |
© 2024 Yahoo. All rights reserved.